among prevalent dialysis patients has been observed in Japan, presumably because of technological advances in dialysis treatment, but further studies are needed to elucidate the contributing factors.
Background
To date, only the Dialysis Outcomes & Practice Patterns Study (DOPPS) has compared dialysis treatment and outcome between Japan and Western countries. DOPPS has shown that when the relative risk (RR) in Japan was defined as 1.0, RR was 2.8 in the United States and 3.8 in Europe, indicating an extremely high risk of death in Western countries [1] . DOPPS also reported that compared with Western countries, Japan had a short dialysis treatment time and a low blood flow and filtration volume (single-pool Kt/V), signifying some unique features of dialysis treatment in Japan. However, the factors contributing to the low mortality rate among Japanese prevalent dialysis patients have not been fully elucidated.
Although DOPPS is a multi-country prospective cohort study, which started in 1996 and is continuing to this day, the study results may not entirely reflect the differ-ences between Japan and Western countries because only about 60 Japanese institutions are participating in the study involving 9,000 patients.
Comparisons between Incident Dialysis Patients
The incidence of patients undergoing renal replacement therapy (RRT) at the end of 2012 was 38,165 in Japan (97.0% undergoing hemodialysis [HD] and 3.0% undergoing peritoneal dialysis [PD]), compared with 114,813 in the United States (89.1% and 8.2%, respectively), and 37,826 in Europe (77.5% and 16.0%, respectively) ( table 1 a). In addition, the number of dialysis patients was 285 per million population in Japan, 359 per million population in the United States, and 150 per million population in Europe [1] [2] [3] .
In Japan and the United States, the mean age of incident dialysis patients has been increasing since 1982, and there has been a notable increase in the incidence among patients aged ≥ 45 years, especially among those ≥ 65 years. However, while the proportion of incident patients aged ≥ 65 at the end of 2012 was 48.3% and 56.1% in the United States and Europe, respectively, the proportion was 65.5% in Japan, clearly showing aging among Japanese patients undergoing dialysis ( table 1 a) [1] [2] [3] .
At the end of 2012, the mean age of incident dialysis patients in Japan was 67.6 years in men and 70.1 years in women. The age pyramid of Japanese dialysis patients divided into 5-year age groups showed the highest incidence in the 75-80 age group in both sexes. In particular, ≥ 1 in 4 female patients (27.5%) were ≥ 80 years old, revealing a large difference in the age distributions between Japan and other countries.
The number of incident patients with end-stage renal disease (ESRD) due to the primary cause of diabetes or hypertension has been increasing rapidly every year since 1980 in the United States, where the proportion of incident dialysis patients who had diabetes stood at 53.3% at the end of 2012. Similarly, the annual incidence is increasing for diabetes and for hypertension in Japan. Because of the difference in clinical criteria used to diagnose primary diseases, glomerulonephritis was the most prevalent cause prior to 1997, but since 1998, diabetes has been the leading primary disease among incident dialysis patients in Japan. Accordingly, the proportion of incident dialysis patients with diabetes increased linearly from 15.6% in 1983 to 44.2% in 2012 and is therefore gradually approaching the proportion observed in Western countries.
Comparisons between Prevalent Dialysis Patients
As of December 2012 the number of prevalent ESRD patients was 309,946 in Japan, 636,905 in the United States, and 284,739 in Europe, with the number increasing each year in all regions ( table 1 b). The number of patients per million population was 2,365, 1,975, and 1,000 per million population, respectively.
With regard to the most common blood purification method used in these regions, the ratio of HD to PD among prevalent dialysis patients in Japan was 96.9: 3.1, indicating that PD use is extremely low; the ratio in the United States was 91.0: 9.0. These proportions were more similar to those of prevalent patients than to those of incident patients ( table 1 b). In addition, over the previous 6 years, the ratio between HD and PD use among prevalent dialysis patients did not differ significantly, suggesting that each country has its own treatment of choice.
The mean age of prevalent dialysis patients has been increasing in both Japan and the United States since 1982, due to the increased number of patients aged ≥ 65. However, the proportion of prevalent dialysis patients aged ≥ 65 at the end of 2012 was 38.4% in the United States, 42.0% in Europe, and 59.8% in Japan, indicating that patients are aging rapidly in Japan ( fig. 1 ) .
With regard to kidney transplantation, the rate was 55.2 per million population in the United States and 30-50 per million population in most European countries as of December 2012. Compared with these high rates, the rate of kidney transplantation in Japan was as low as 12.6 per million population and is characterized by a large proportion of living donors.
Another unique characteristic of Japanese dialysis patients is that large numbers undergo dialysis for an extended period of time, primarily because of the low rate of kidney transplantation. Figure 2 shows chronological changes over 5-year periods between 1992 and 2012 in the number of Japanese dialysis patients based on duration of dialysis and stratified by age. The proportion of patients with a duration of dialysis of ≥ 25 years can be seen to have increased from 1.0% to 7% over a 10-year period. Thus, not only the age of dialysis patients, but also the number of patients undergoing dialysis for lengthy periods has been increasing. Table 2 shows patient characteristics based on the duration of dialysis. As the years of dialysis increased, body mass index decreased in a linear fashion, whereas single-pool Kt/V increased gradually. In addition, except for certain years, levels remained largely the same for normalized protein catabolic rate (g/kg/day), hemoglobin, serum albumin, corrected calcium, and phosphorus. However, albumin tended to decrease in patients who had been undergoing dialysis for more than 35 years. In summary, DOPPS has revealed that certain aspects of dialysis treatment are unique to Japan, but the factors contributing to the low mortality rate among Japanese patients are currently unknown. In Japan, dialysis patients are aging rapidly, and the incidence of diabetes-an important prognostic factor in prevalent dialysis patients-has been increasing every year and is approaching the rates observed in the United States and Europe. Despite these observations, it is unclear why the crude death rate among Japanese dialysis patients has not declined significantly. Further study is needed to clarify whether technological developments in dialysis treatment have contributed to the low crude death rate in Japan.
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